| Formulary Chapter 10: Musculoskeletal and joint diseases - Full Section
|
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
10.01 |
Drugs used in rheumatic diseases and gout (0,0)
|
|
|
Rheumatoid arthritis and other inflammatory disorders (0,0)
|
|
|
Osteoarthritis and soft-tissue disorders
(0,4)
|
|
10.01.01 |
Non-steroidal anti-inflammatory drugs
(17,2)
|
|
|
Aspirin (0,0)
|
|
10.01.02 |
Corticosteroids (0,0)
|
|
10.01.02.01 |
Systemic corticosteroids (0,0)
|
|
10.01.02.02 |
Local corticosteroids injections
(4,0)
|
|
10.01.03 |
Drugs which suppress the rheumatic disease process
(1,0)
|
|
|
Gold
(1,0)
|
|
|
Penicillamine
(1,0)
|
|
|
Antimalarials
(1,0)
|
|
|
Drugs affecting the immune response
(15,1)
|
|
|
Sulfasalazine
(1,0)
|
|
10.01.04 |
Gout and cytotoxic-induced hyperuricaemia (0,0)
|
|
|
Acute attacks of gout
(1,0)
|
|
|
Long-term control of gout
(2,0)
|
|
|
Hyperuricaemia associated with cytotoxic drugs
(1,0)
|
|
10.01.05 |
Other drugs for rheumatic diseases
(1,1)
|
|
10.02 |
Drugs used in neuromuscular disorders (0,0)
|
|
10.02.01 |
Drugs which enhance neuromuscular transmission (0,0)
|
|
|
Anticholinesterases
(4,0)
|
|
|
Immunosuppressant therapy (0,0)
|
|
|
Acetylcholine-release enhancers (0,0)
|
|
10.02.02 |
Skeletal muscle relaxants
(4,1)
|
|
|
Other muscle relaxants (0,0)
|
|
|
Nocturnal leg cramps
(1,0)
|
|
10.03 |
Drugs for the relief of soft-tissue inflammation and topical pain relief (0,0)
|
|
|
Extravasation (0,0)
|
|
10.03.01 |
Enzymes
(0,2)
|
|
10.03.02 |
Rubefacients, topical NSAIDs, capsaicin, and poultices
(0,2)
|
|
|
Topical NSAIDs and counter-irritants
(2,1)
|
|
|
Capsaicin
(2,1)
|
|
|
Poultices (0,0)
|
